Welcome to Wellness Center
Institute for Education, Research, and Scholarships (IFERS)
Health and Wellness
The 501(c)(3) nonprofit Institute for Education, Research, and Scholarships (IFERS) Wellness Center supports advanced research and applies integrative solutions with state-of-the-art technologies to achieve affordable physical and mental healthcare as well as elimination of diseases cost-effectively, resulting in better quality of life and longevity.
Email: wellness@ifers.org
Immune System Rejuvenation
Our Wellness Team conducted an interview with Dr. Greg Fahy in California on February 28, 2020 about immune system rejuvenation for protecting humans from COVID-19 coronavirus and antibiotics-resistant superbugs.
Autism Research
Neurodiverse individuals are frequently misunderstood, bullied, or ostracized. They are even occasionally unknowingly mistreated by friends, relatives, or caregivers who do not know how to handle them. Right now, there is not enough information available to truly hand tailor the treatment of people living on the spectrum. Identifying, treating, and educating those around them can vastly improve the quality of their lives.
We are creating a research database to explore the autism spectrum and better understand neurodiversity. The genetic and psychological database on autistic and Asperger's will be analyzed to create a World’s Best Practice (WBP) for the United Nations World Health Organization (WHO).
Type 1 Diabetes
We are partnering with EASE T1D nonprofit to bring:
1. EDUCATION to medical professionals, school staff, and to the general public about how to treat and care for children with type 1 diabetes.
2. AWARENESS on the differences between type 1 and type 2 diabetes as well as encourage the implementation of legislation on the signs and symptoms of type 1 diabetes to parents at all well baby/child care visits, in an effort to prevent misdiagnosis.
3. SUPPORT to our T1D community through the sharing of resources, family events, and personal experiences.
4. EMPOWERMENT to the families through assistance, knowledge, and unity.
SUKHI 222
SUKHI 222 educates, advocates, and participates in development of tools and best practices to insure the biological need and human right of all people of dignified access to 2 gallons of fresh water, 2,000 nutritional calories and 200 ft3 of secure shelter. We prioritize the use of our resources toward the identification and development of scalable, sustainable, and systemic best practices required to fastest achieve the UN SDG’s.
Advisory Board
Dr. Greg Fahy, Ph.D.
Dr. Greg Fahy, Intervene Immune, received his Ph.D. in pharmacology and cryobiology from the Medical College of Georgia in 1977 and worked at the American National Red Cross on kidney banking at cryogenic temperatures (cryopreservation) from 1977-1995.
He worked at the Naval Medical Research Institute and served as the Chief Scientist of two biotechnology companies from 1995-1997, until moving to California to join 21st Century Medicine (21CM) in 1998, where he rapidly became the Chief Scientific Officer (CSO) and Vice President of the company. While he is mostly known for his work on fundamental cryobiology and kidney cryopreservation, he has also had a lifelong fascination with the biology of aging, and in 2010 published a multi-authored book called The Future of Aging: Pathways to Human Life Extension as the editor-in-chief.
In addition to continuing to serve as the CSO of 21CM, Dr. Fahy is currently conducting a human clinical trial of aging reversal based at Stanford University, the focus being on reversal of human immune system aging, which is believed to be a major cause of death and illness in people over the age of 65. Some notable recent accomplishments include publication of the first paper demonstrating survival of a kidney after cooling to -130oC, rewarming, and transplantation; the winning, with coworker Robert McIntyre, of the Small Mammal Brain Preservation Prize; the achievement of institutional and FDA approval for his first human clinical trial; and 2 years of progress in his clinical trial with no serious side effects, and with great enthusiasm on the part of trial volunteers.
Current research includes demonstrating greatly improved methods of organ banking, the elimination of human autoimmune disorders, and the elimination of transplant rejection.
Dr. Cynthia Foster, M.D.
Dr. Cynthia Foster received her M.D. degree in 1996 from the University of Texas Health Science Center at San Antonio. Due, in part, to her own natural healing from epilepsy without medications or surgery in her last year of medical school, she developed an interest in helping others heal naturally from incurable diseases. Dr. Foster has spent more than 20 years in developing natural healing protocols and counseling patients. Since there were no medical doctors who were practicing holistically when Dr. Foster began her 100% holistic practice in 1997, she founded Dr. Foster's Essentials as an educational website to teach people how to heal themselves naturally and at home, without expensive lab tests or other medical interventions.
Prof. Newton Lee, Hon.D.
Prof. Newton Lee, Hon.D. received his B.S. and M.S. degree in Computer Science from Virginia Tech, and his A.S. degree in Electrical Engineering and honorary doctorate in Computer Science from Vincennes University.
He is the founding president of the 501(c)(3) nonprofit Institute for Education, Research, and Scholarships based in Los Angeles, California. He is a former Disney and Bell Labs engineer, and a 2021 graduate of the FBI Citizens Academy.
Serving as an FBI Ambassador, Lee expounds on social media, campus safety, student mental health, cybersecurity, and counterterrorism as portrayed in the highly acclaimed Total Information Awareness book series published by Springer Nature.
His book The Transhumanism Handbook stayed as the #1 New Release in Preventive Medicine on Amazon.com for 4 months since April 2019.
His first peer-reviewed research paper was “An Expert System for Information on Pharmacology and Drug Interactions” published in the International Journal of Computers in Biology and Medicine.
He was offered a research scientist job at Mayo Clinic in Rochester, Minnesota. He has been honored with a Michigan Leading Edge Technologies Award, two community development awards from the California Junior Chamber of Commerce, and four volunteer project leadership awards from The Walt Disney Company.
He believes in the power of citizen scientists, human-machine symbiosis, and artificial superintelligence in solving tough problems. In his book chapter "Google Versus Death: To Be, Or Not to Be?", he cites the computer game "Foldit" that took less than 10 days in September 2011 for its players to decipher the AIDS-causing Mason-Pfizer monkey virus that had stumped scientists for 15 years.
To put science, health, and technology at the forefront of American politics, Lee is the chairman of the California Transhumanist Party, and the education and media advisor to the United States Transhumanist Party.
Lima Jevremović
Lima Jevremović is the founder of AURA (Autonomous User Rehabilitation Agent) and Jevremovic Institute of Behavior and Brain Sciences (JIBBS). Having lived the implications of severe mental health illness first hand through loved ones, Lima has created a Virtual Rehabilitation Program that builds and provides the highest quality Virtual Reality and digital treatment tools for mental health, substance abuse and addictions. The VR solution targets contributing factors such as trauma, anxiety, depression and high risk personality traits in controlled virtual environments to form new behavioral patterns. Bridging the gap between inpatient and outpatient facilities, the VR program offers mobile solutions to keep patients on track to reduce relapse and the rate of recidivism.
Dr. Elena Rusyn, M.D.
Dr. Elena Rusyn is board-certified in anti-aging and regenerative medicine. She received her M.D. degree from National Medical University in Kiev, Ukraine and completed her residency training in Allergy and Immunology with sub-specialty in Cardiology. After her medical residency, she continued her postdoctoral studies at UNC-Chapel Hill Radiation Oncology Department, Harvard Medical School/MGH Department of Cancer Cell Biology, Gray Cancer Institute (London, UK), and Duke University Medical Center Departments of Neurobiology and MGM.
A medical scientist dedicated to enhancing the quality of life and extending the length of the human lifespan, she is the CEO of AmpliCell Medical, a company committed to tackling aging with an interdisciplinary approach and advancing stem cell regenerative medicine and research. She has worked around the globe as a women’s health and hormone specialist. Among her many awards are the Individual Postdoctoral National Research Service Award, NIEHS.
She was appointed as a senior Immuno-Oncology scientist in Syntherica corporation where she contributed to developing and applying the surrogate antibodies technology in medical diagnostics.
Elena was a member of a team involved in research on understanding molecular mechanisms of cellular responses to oxidative stress from ionizing radiation. She contributed to the evaluation of the human health risk associated with exposures to low doses of ionizing radiation as well as the following cellular responses to ionizing radiation: apoptosis, DNA damage, gene expression, the bystander and low-dose hypersensitivity effects, genomic instability and mechanisms for regulation of DNA damage response by cell-cell communication.
She contributed to the discovery of the biological function of CLN3 protein and demonstrated that CLN3 binds to the sphingolipid galactosylceramide and aids in its transport from Golgi to lipid rafts. She showed that treatment with galactosylceramide partially restores the neurodegeneration caused by juvenile neuronal ceroid lipofuscinosis, a neurodegenerative disease caused by CLN3 mutation, and that it could be developed as a new therapeutic option.
She discovered that increased radiosensitivity of R-Ras oncogene expressing cells could be due to elevated oxidant production that exhausting antioxidant defense in those cells. Moreover, R-Ras overexpressing cells underwent type II physiological cell death (autophagy) in response to inhibition of p38 kinase, the potential for the therapeutic application.
Her work has been presented internationally and published in renowned peer-reviewed journals such as the Journal of Cell Biology, Oncogene, Cancer Research, Cell Host and Microbe, Nutrition and Cancer, Pediatric Research and the Journal of Immunology and Allergy.
Dr. Anca Selariu, Ph.D.
Dr. Anca Selariu received her Ph.D. in Integrative Biomedical Sciences from Rutgers University where she developed an alternative vaccine for chickenpox and shingles. Her education also includes a Bachelor’s degree in Biochemistry and one in Philology, as well as various studies in astrobiology, psychology, criminology, and nutrition.
She is an interdisciplinary biomedical scientist, philologist and incurable optimist. She shares a vision for an inter-galactic humanity within the next thousand years, and sees each human being alive today as a precious resource to realize this potential. She seeks to dedicate her efforts to three causes: 1) creating human bio-enhancements and anti-aging therapies using interdisciplinary knowledge and tools available, which will allow humanity to keep up and co-evolve with its own brain products; 2) educating the world on mental flexibility, so that prejudice, fear and discrimination become obsolete; 3) help design an ergonomic habitat for the far-future humanity, both on and above Terra.
She believes that our collective mind will always seek to conquer the impossible, and we owe the future humans the best of what we can do today. In March 2018, she gave a talk at TEDxCSU entitled "Future of life and the importance of being unreasonable", in which she proposed that, because evolution is not optional but rather a mathematical condition of existence, it is necessary that humans learn to use their ability for higher achievements in order to intentionally direct their evolution and to mitigate existential risk for all life on earth.
She has twelve years of biomedical research in herpes viruses and transmissible spongiform encephalopathies, and three years in FDA/CGMP project management and business development. She is a founding member of the Future of Thought Consortium, and a member of the Association for the Advancement of Artificial Intelligence (AAAI), Society for Neuroscience (SfN), American Society for Microbiology (ASM), and Eastern Psychology Association (EPA). In her spare time, she enjoys creative writing, painting, maintaining a healthy mind-body connection and attending scientific conferences.